Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
Status:
Not yet recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This pilot study will evaluate study processes and feasibility of a future large-scale
clinical trial that proposes to test whether low-risk children managed as outpatients with
community-acquired pneumonia (CAP) and procalcitonin (PCT) levels <0.25 ng/mL treated with
placebo have a similar clinical response to those treated with antibiotics and fewer adverse
effects.
Phase:
Phase 4
Details
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators:
Children's Hospital Medical Center, Cincinnati Children's Hospital of Philadelphia University of Utah